Geneva, June 16 -- International Clinical Trials Registry received information related to the study (ACTRN12625000575437) titled 'Part A Phase I, Single Ascending Dose Trial of Agomelatine in Healthy Participants' on June 3.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Primary Sponsor: Seaport Therapeutics Australia Pty LTD
Condition:
Anxiety
Anxiety
Mental Health - Anxiety
Intervention:
This study evaluates the safety, tolerability, pharmacokinetics (PK), and preliminary pharmacodynamics of agomelatine following a single oral dose in healthy adult participants.
Part A - Agomelatine
Intervention: Single oral dose of Agomelatine
Dose: One cohort of up to 10 subjects will receive a ...